Shanghai CP Guojian Pharmaceutical Co Ltd - Company Review
Shanghai CP Guojian Pharmaceutical Co Ltd - Company ReviewSummary
Shanghai CP Guojian Pharmaceutical Co Ltd (CPGJ) is a biopharmaceutical company that develops antibodies drugs. The company provides pilot scale development, industrialization and commercialization of antibody drugs. Its products include yisaipu and xenapax. CPGJ’s pipeline products comprise anti-HER2 monoclonal antibody, anti-CD20 chimeric monoclonal antibody, and human CTLA4-antibody fusion protein. The company offers treatment of cancer, organ transplant anti-rejection, autoimmune diseases, and other diseases. Its technologies include animal cell culture technology, animal cell suspension culture technology, animal cell culture technology and antibody pharmaceutical formulation technology. The company markets its products in Mexico, Panama, Colombia, Ecuador, India and Paraguay. CPGJ is headquartered in Shanghai, China.
This comprehensive company report of Shanghai CP Guojian Pharmaceutical Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.